首页> 外文期刊>Medicine. >Medium-Based Noninvasive Preimplantation Genetic Diagnosis for Human α-Thalassemias-SEA
【24h】

Medium-Based Noninvasive Preimplantation Genetic Diagnosis for Human α-Thalassemias-SEA

机译:基于介质的人α-地中海贫血-SEA的无创植入前遗传学诊断

获取原文
获取外文期刊封面目录资料

摘要

To develop a noninvasive medium-based preimplantation genetic diagnosis (PGD) test for α-thalassemias-SEA. The embryos of α-thalassemia-SEA carriers undergoing in vitro fertilization (IVF) were cultured. Single cells were biopsied from blastomeres and subjected to fluorescent gap polymerase chain reaction (PCR) analysis; the spent culture media that contained embryo genomic DNA and corresponding blastocysts as verification were subjected to quantitative-PCR (Q-PCR) detection of α-thalassemia-SEA. The diagnosis efficiency and allele dropout (ADO) ratio were calculated, and the cell-free DNA concentration was quantitatively assessed in the culture medium. The diagnosis efficiency of medium-based α-thalassemias–SEA detection significantly increased compared with that of biopsy-based fluorescent gap PCR analysis (88.6% vs 82.1%, P –SEA detection is Day 5 (D5) following IVF. Medium-based α-thalassemias–SEA detection could represent a novel, quick, and noninvasive approach for carriers to undergo IVF and PGD.
机译:要开发基于非侵入性介质的α-地中海贫血的植入前遗传诊断(PGD)测试, -SEA 。培养了进行了体外受精(IVF)的α地中海贫血的胚胎。从卵裂球活检单个细胞,并进行荧光缺口聚合酶链反应(PCR)分析;对包含胚胎基因组DNA和相应胚泡作为验证的废培养基进行α-地中海贫血的定量PCR(Q-PCR)检测 -SEA 。计算诊断效率和等位基因缺失(ADO)比率,并在培养基中定量评估无细胞DNA浓度。与基于活检的荧光间隙检测相比,基于中等水平的地中海贫血的诊断效率显着提高。 PCR分析(88.6%对82.1%,P –SEA 检测是在IVF后的第5天(D5)。基于培养基的α-地中海贫血 – SEA 检测可以为携带者进行IVF和PGD提供一种新颖,快速且无创的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号